Loading...
Thumbnail Image
Publication

Synthesis, biological profiling and mechanistic studies of 4-aminoquinoline-based heterodimeric compounds with dual trypanocidal–antiplasmodial activity.

Sola, I.
Castellà, S.
Viayna, E.
Galdeano, C.
Taylor, M.C.
Gbedema, Stephen Y.
Pérez, B.
Clos, M.V.
Jones, D.C.
Fairlamb, A.H.
... show 3 more
Publication Date
2015-08
End of Embargo
Supervisor
Rights
© 2015 Elsevier. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Additional title
Abstract
Dual submicromolar trypanocidal–antiplasmodial compounds have been identified by screening and chemical synthesis of 4-aminoquinoline-based heterodimeric compounds of three different structural classes. In Trypanosoma brucei, inhibition of the enzyme trypanothione reductase seems to be involved in the potent trypanocidal activity of these heterodimers, although it is probably not the main biological target. Regarding antiplasmodial activity, the heterodimers seem to share the mode of action of the antimalarial drug chloroquine, which involves inhibition of the haem detoxification process. Interestingly, all of these heterodimers display good brain permeabilities, thereby being potentially useful for late stage human African trypanosomiasis. Future optimization of these compounds should focus mainly on decreasing cytotoxicity and acetylcholinesterase inhibitory activity.
Version
Accepted manuscript
Citation
Sola I, Castella S, Viayna E et al (2015) Synthesis, biological profiling and mechanistic studies of 4-amonoquinoline-based heterodimeric compounds with dual trypanocidal-antiplasmodial activity. Bioorganic and Medicinal Chemistry. 23(16): 5156-5167.
Link to publisher’s version
Link to published version
Type
Article
Qualification name
Notes